Literature DB >> 12147094

Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in human crescentic glomerulonephritis.

K C Moon1, S Y Park, H W Kim, H K Hong, H S Lee.   

Abstract

AIMS: In glomerulonephritis, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) may play important roles in the formation of crescents. These studies are designed to evaluate the expression patterns of ICAM-1 and VCAM-1 in human crescentic glomerulonephritis and to determine the cellular origin of adhesion molecules in the crescentic lesions. METHODS AND
RESULTS: We examined the expression of ICAM-1 and VCAM-1 proteins in renal biopsies with cellular (n=7), fibrocellular (n=9) or fibrous (n=4) crescentic glomerulonephritis, and six controls by immunohistochemistry. mRNA expression of ICAM-1 and VCAM-1 was further evaluated by RNA in-situ hybridization. Cytokeratin or CD68 immunohistochemistry was performed on the same sections, where in-situ hybridization had been carried out. In cellular crescents, ICAM-1 and VCAM-1 proteins were over-expressed to a similar extent. Of the three types of crescents, the extent of ICAM-1 immunopositivity was the greatest in the cellular crescents and decreased towards the fibrous crescents (P < 0.05). Yet the extent of VCAM-1 immunoreactivity was not different between the types. Fibrous crescents still contained some epithelial cells and showed only VCAM-1 expression. In the glomeruli with cellular or fibrocellular crescents, the extent of ICAM-1 immunopositivity in the glomerular tufts was significantly larger than that of VCAM-1 (P < 0.05). In an in-situ hybridization study, the mRNA expression patterns of ICAM-1 and VCAM-1 paralleled their protein expressions. A double-labelling study showed that the signal for ICAM-1 and VCAM-1 mRNAs was mainly present in cytokeratin-positive and CD68-negative cells in the crescentic lesions.
CONCLUSIONS: These results suggest that glomerular parietal epithelial cells in cellular crescents up-regulate both ICAM-1 and VCAM-1, and that some epithelial cells retained in fibrous crescents persistently over-express VCAM-1, but not ICAM-1. They also suggest that ICAM-1 is involved in early leucocyte recruitment into glomeruli in crescentic glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147094     DOI: 10.1046/j.1365-2559.2002.01446.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis.

Authors:  Markus Wörnle; Holger Schmid; Bernhard Banas; Monika Merkle; Anna Henger; Maximilian Roeder; Simone Blattner; Elisabeth Bock; Matthias Kretzler; Hermann-Josef Gröne; Detlef Schlöndorff
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  Sustained monocyte activation in clinical remission of systemic vasculitis.

Authors:  Agneta Wikman; Joachim Lundahl; Stefan H Jacobson
Journal:  Inflammation       Date:  2008-12       Impact factor: 4.092

Review 3.  The Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western Countries.

Authors:  Sophia Lionaki; John N Boletis
Journal:  Kidney Dis (Basel)       Date:  2015-12-05

4.  TLR3-dependent immune regulatory functions of human mesangial cells.

Authors:  Monika Merkle; Andrea Ribeiro; Simone Köppel; Joachim Pircher; Hanna Mannell; Maximilian Roeder; Markus Wörnle
Journal:  Cell Mol Immunol       Date:  2012-04-02       Impact factor: 11.530

5.  Renal expression of adhesion molecules in anca-associated disease.

Authors:  P Arrizabalaga; M Solé; R Abellana; C Ascaso
Journal:  J Clin Immunol       Date:  2008-06-24       Impact factor: 8.317

Review 6.  Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis.

Authors:  Sofia Lionaki; J Charles Jennette; Ronald J Falk
Journal:  Semin Immunopathol       Date:  2007-10-18       Impact factor: 9.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.